ESC Premium Access

Non-vitamin K oral anticoagulants for cardioversion: recent trials.

Congress Presentation

About the speaker

Professor Michael Ezekowitz

Thomas Jefferson University Hospital, Philadelphia (United States of America)
4 presentations
0 follower

3 more presentations in this session

Early cardioversion: is there strong evidence to support the concept?

Speaker: Professor P. Kirchhof (Hamburg, DE)


Practical considerations for cardioversion of atrial fibrillation.

Speaker: Doctor R. Cappato (Milan, IT)


Dealing with left atrial appendage clot

Speaker: Associate Professor F. Marin (Murcia, ES)


Access the full session

Anticoagulation for cardioversion of atrial fibrillation: exploring areas of uncertainty

Speakers: Professor M. Ezekowitz, Professor P. Kirchhof, Doctor R. Cappato, Associate Professor F. Marin

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb